Aquilo Capital Management as of March 31, 2022
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 14 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p Biotech Etf Tr Unit Call Option (XBI) | 26.4 | $180M | 2.0M | 89.88 | |
| Spdr S&p 500 Etf Tr Unit Put Option (SPY) | 23.2 | $158M | 350k | 451.64 | |
| Blueprint Medicines (BPMC) | 7.3 | $50M | 782k | 63.88 | |
| Arrowhead Pharmaceuticals (ARWR) | 7.1 | $48M | 1.0M | 45.99 | |
| Arvinas Ord (ARVN) | 6.9 | $47M | 695k | 67.30 | |
| Spero Therapeutics (SPRO) | 6.8 | $46M | 5.3M | 8.70 | |
| Regenxbio Inc equity us cm (RGNX) | 5.5 | $37M | 1.1M | 33.19 | |
| Merus N V (MRUS) | 4.9 | $33M | 1.3M | 26.44 | |
| 4d Molecular Therapeutics In (FDMT) | 3.9 | $27M | 1.8M | 15.12 | |
| Uniqure Nv SHS (QURE) | 2.4 | $16M | 902k | 18.07 | |
| Amryt Pharma Sponsored Ads | 2.0 | $14M | 1.6M | 8.27 | |
| Pieris Pharmaceuticals (PIRS) | 1.7 | $11M | 3.7M | 3.03 | |
| Argenx Se Sponsored Adr (ARGX) | 1.1 | $7.6M | 24k | 315.29 | |
| Genmab A/s Sponsored Ads (GMAB) | 0.9 | $6.1M | 168k | 36.18 |
